The MoO 3 /TiO 2 /Ti 3 C 2 T x composite was synthesized by a simple one-step hydrothermal method. Due to the formation of more active centers and heterojunctions, the sensor has excellent performance for VOCs and has a unique response to isopropanol.
Simultaneous detection of uric acid and glucose using a non-invasive approach can be a promising strategy for related diseases, e.g., diabetes, gout, kidney disease, and cardiovascular disease. In this study, we have proposed a dual-function wearable electrochemical sensor for uric acid and glucose detection in sweat. The sensor with a four-electrode system was prepared by printing the ink on a common rubber glove. CV and chronoamperometry were used to characterize the prepared sensor’s electrochemical sensing performance. The sensors exhibited the linear range from 0 to 1.6 mM and 0 to 3.7 mM towards uric acid and glucose electrochemical sensing in phosphate-buffered solution, with the corresponding limit of detection of 3.58 μM and 9.10 μM obtained, respectively. Moreover, the sensors had shown their feasibility of real sample sensing in sweat. The linear detection range for uric acid (0 to 40 μM) and glucose (0 to 1.6 mM) in the sweat can well cover their concentration range in physiological conditions. The prepared dual-function wearable electrochemical sensor features easy preparation, fast detection, high sensitivity, high selectivity, and the practical application potential in uric acid and glucose sensing.
The development of a straightforward, economical, portable, and highly sensitive sensing platform for the rapid detection of cholesterol is desirable for the early diagnosis of several pathologic conditions. In this work, we present a fascinating skin-worn microneedle sensor for monitoring cholesterol in interstitial fluid samples. The microneedle sensor was developed by incorporating platinum (Pt) and silver (Ag) wires within pyramidal microneedles containing a microcavity opening; cholesterol oxidase (ChOx) was coupled on the Pt transducer surface using bovine serum albumin and Nafion. Under optimal conditions, the enzymatic microneedle sensor exhibited high sensitivity (0.201 μA μM−1) towards cholesterol in buffer solution, with good linearity over the 1–20 μM range and a correlation coefficient of 0.9910. The analytical performance of the microneedle sensor was also investigated in artificial interstitial fluid and a skin-mimicking phantom gel; the sensor showed great potential for skin-worn/wearable applications with excellent linearity and a low detection limit. In addition, the developed microneedle sensor showed satisfactory stability and good selectivity towards cholesterol in the presence of potential interfering biomolecules, including glucose, lactic acid, uric acid, and ascorbic acid. This sensor exhibits enormous promise for straightforward, sensitive, and minimally invasive monitoring of cholesterol.
Microneedle technology advances healthcare with drug release, biosensing and theranostic systems. While promising, issues including production require multidisciplinary efforts to bridge the gap between research and individualized healthcare devices.
Achieving quantification of biomarkers in body fluids is crucial to the indication of the state of a person’s body and health. Wearable sensors could offer a convenient, fast and painless sensing strategy. In this work, we fabricated a wearable electrochemical patch sensor for simultaneous detection of dopamine and glucose in sweat. The sensor was printed on a flexible PDMS substrate with a simple screen-printed method. This prepared four-electrode sensor integrated two working electrodes for dopamine and glucose electrochemical sensing, one Ag/AgCl reference electrode and one carbon counter electrode, respectively. Cyclic voltammetry, differential pulse voltammetry and chronoamperometry were used for the evaluation of the wearable electrochemical patch sensor. It exhibits good sensitivity, wide linear range, low limit of detection, good anti-interference and reproducibility toward dopamine and glucose sensing in PBS and sweat.
8 April 2024 in Journal of Biomaterials Science, Polymer Edition
1. Transdermal drug delivery through skin offers minimally invasive and painless transdermal characteristics that circumvents the gastrointestinal irritation of oral drugs and the hepatic first-pas...